SLRN: Acelyrin, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Acelyrin, Inc.

NASDAQ:SLRN

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$2.27
Loss Chance
59.6%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Related
AbbVie
NYSE:ABBV
5.85
$202.71
115.94%
BioMarin Pharmaceutical
NASDAQ:BMRN
6.13
$54.12
4.67%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.28
$31.17
42.08%
CytomX Therapeutics
NASDAQ:CTMX
1.99
$4.00
100.00%
Genmab A/S
NASDAQ:GMAB
6.50
$27.06
7.57%
Jitta Factors
Growth Opportunity (10)
Recent Business Performance (25)
Financial Strength (23)
Return to Shareholders (0)
Competitive Advantage (1)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
2.48
473.03%
2.48
473.03%
COMPANY DESCRIPTION
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company’s lead product candidate is lonigutamab, a subcutaneously delivered monoclonal antibody targeting IGF-1R, which has completed Phase 2 clinical trial for the treatment of Thyroid Eye Disease (TED). Acelyrin, Inc. was incorporated in 2020 and is based in Agoura Hills, California. As of May 21, 2025, Acelyrin, Inc. operates as a subsidiary of Alumis Inc.
www.acelyrin.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.